Dr Reddys Laboratories (RDY) Cash from Discontinued Operations (2011 - 2017)

Dr Reddys Laboratories (RDY) has reported Cash from Discontinued Operations for 5 consecutive years, with 7520000000.0 the latest figure, recorded in Q4 2017.

• Quarterly Cash from Discontinued Operations rose 43.7% year-over-year to 7520000000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 22169000000.0 (up 49.51% YoY) and the FY2013 annual result came in at 13317000000.0, down 17.54% from the prior year.
• Cash from Discontinued Operations grew to 7520000000.0 in Q4 2017 per RDY's latest filing, from 6707000000.0 in the prior quarter.
• Over the last five years, Cash from Discontinued Operations for RDY reached as high as 7520000000.0 in Q4 2017 and fell as low as 836000000.0 in Q3 2013.
• A 3-year average of 4515000000.0 and a median of 4861000000.0 in 2013 frame the typical range for Cash from Discontinued Operations.
• Annual changes were most pronounced in 2013 — Cash from Discontinued Operations sank 74.87% — and 2017, when it surged 147.58%.
• Year by year, Cash from Discontinued Operations stood at 6050000000.0 in 2013, then dropped by 13.5% to 5233000000.0 in 2016, then soared by 43.7% to 7520000000.0 in 2017.
• According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 7520000000.0, 6707000000.0, and 5233000000.0 for Q4 2017, Q3 2017, and Q4 2016 respectively.